2Gegenhuber A, Muller T, Firlinger F, et al. Time course of B-type natriuretic peptide (BNP) and N-terminal proBNP changes in patients with decompensated heart failure [J]. Clin Chem,2004,50(2) :454. 被引量：1
3Kuster GM,Tanner H, Printzen G. B-type natriuretic peptide for diagnosis and treatment of congestive heart failure [ J]. Swiss Med Wkly, 2003,33 (3) :623. 被引量：1
4Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B- type natriuretic peptide (BNP) [J] .Eur Heart J,2003,24:1710. 被引量：1
5Horwich TB,Patel J,MacLellan WR,et al.Cardiac troponin I is associated with impaired hemodynamics,progressive left ventricular dysfunction,and inreased mortality rates in advanced heart failure[J].Circulation,2003,108(7):833-838. 被引量：1
6Dao Q,Krishnaswamy P,Kazanegra R,et al.Utility of CHF in an urgent-care setting[J].Am Coll Cardiol,2001,37(2):379-385. 被引量：1
7Mueller C,Scholer A,Laule-Kilian K,et al.Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea[J].N Engl J Med,2004,350(7):647-654. 被引量：1
8Ishii J,Nomura M,Nakamura Y,et al.Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure[J].Am J Cardiol,2002,89(6):691-695. 被引量：1
